Trident Lifeline Limited

543616

INE0MKA01014

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:54 24/05/2024 pm IST			5-day change	1st Jan Change
169 ^INR	-5.59%		-3.84%	-10.11%

17/05	Trident Lifeline's CFO Resigns	MT
27/04	Trident Lifeline Limited Announces Board and Committee Changes	CI

Trident Lifeline Limited agreed to acquire 18% stake in Tricorp Industries Limited for INR 0.18 million.

July 20, 2023

Trident Lifeline Limited (BSE:543616) agreed to acquire 18% stake in Tricorp Industries Limited for INR 0.18 million on July 20, 2023. The transaction is expected to close within a month.

Latest news about Trident Lifeline Limited

Trident Lifeline's CFO Resigns	17/05	MT
Trident Lifeline Limited Announces Board and Committee Changes	27/04	CI
Trident Lifeline Limited Reports Earnings Results for the Full Year Ended March 31, 2024	27/04	CI
Trident Lifeline Commissions Manufacturing Units in Surat, India	26/04	MT
Trident Lifeline Incorporates Wholly Owned Arm	16/04	MT
Trident Lifeline Limited Approves the Proposal of Incorporation of A Wholly Owned Subsidiary	06/04	CI
Trident Lifeline Limited Announces Appointment of Jiteshkumar Ramchandra Varkal as Company Secretary and Compliance Officer	11/12	CI
Trident Lifeline Limited Announces Resignation of Kunal Amrishbhai Chauhan from the Post of Company Secretary and Compliance Officer	30/11	CI
Trident Lifeline Limited Reports Earnings Results for the Half Year Ended September 30, 2023	04/11	CI
5,649,460 Equity Shares of Trident Lifeline Limited are subject to a Lock-Up Agreement Ending on 16-OCT-2023.	16/23/16	CI
Trident Lifeline Completes Acquisition of 51% Stake in TLL Herbal	10/23/10	MT
Trident Lifeline Limited completed the acquisition of TLL Herbal Limited.	10/23/10	CI
Trident Lifeline Limited completed the acquisition of 18% stake in Tricorp Industries Limited.	25/23/25	CI
Trident Lifeline to Acquire 18% Stake in Indian Chemicals Manufactuer	21/23/21	MT
Trident Lifeline Limited agreed to acquire 18% stake in Tricorp Industries Limited for INR 0.18 million.	20/23/20	CI
Trident Lifeline Gets Board Nod to Acquire Majority Stake in TLL Herbal	17/23/17	MT
Trident Lifeline Limited Announces the Resignation of Mr. Dhavl V Shah as Independent Director	15/23/15	CI
Trident Lifeline Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	15/23/15	CI
Trident Lifeline Limited agreed to acquire 51% stake in Tll Herbal Limited from existing shareholders for INR 0.51 million.	15/23/15	CI
Trident Lifeline Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	06/23/06	CI
Trident Lifeline Limited Reports Earnings Results for the Full Year Ended March 31, 2023	06/23/06	CI
Trident Lifeline Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	16/23/16	CI
Trident Lifeline Raises Stake in TNS Pharma to 51%	22/22/22	MT
Trident Lifeline Limited acquired 51% stake in TNS Pharma Private Limited.	22/22/22	CI
Trident Lifeline Limited has completed an IPO in the amount of INR 353.4192 million.	06/22/06	CI

Chart Trident Lifeline Limited

Duration

Period

More charts

Trident Lifeline Limited is an India-based pharmaceutical company, which is engaged in providing of capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders, and toothpaste. The Company operates through seven geographical segments: India, Ghana, Kenya, Nigeria, Cameroon, Venezuela, Rest of World. The Company offers a range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. It deals in capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders, and toothpaste. Its product portfolio includes a range of drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozoal, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, Non-Steroidal Anti-Inflammatory Drug (NSAIDS).

Sector

Pharmaceuticals

Calendar

15/07/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TRIDENT LIFELINE LIMITED	-10.11%	2.47Cr
ELI LILLY AND COMPANY	+38.51%	73TCr
NOVO NORDISK A/S	+33.05%	60TCr
JOHNSON & JOHNSON	-6.23%	36TCr
MERCK & CO., INC.	+18.78%	33TCr
ABBVIE INC.	+1.35%	28TCr
ASTRAZENECA PLC	+16.00%	24TCr
NOVARTIS AG	+8.09%	21TCr
ROCHE HOLDING AG	-5.77%	21TCr
AMGEN INC.	+6.19%	16TCr